About Us
Partnering with exceptional people to ensure a brighter tomorrow for all
Asian Healthcare Fund (AHF) is a premier Private Equity platform in the healthcare and related sectors, with a track record of successfully backing across two Funds, innovators & entrepreneurs with the potential to change the healthcare landscape.
AHF has the track record of two Private Equity Funds with the full life cycle completed for Fund I while Fund II has demonstrated good traction since inception.
Our philosophy
Most Indian Healthcare businesses, other than Pharmaceutical companies and hospitals in big metro cities, are in early stages of growth and face significant challenges in their growth journey. It is, therefore, important to engage with the Founders and their business teams in both Strategic & Operational areas to help them address these challenges
Given AHF’s extensive operating experience, combined with the team’s deep understanding of the Healthcare domain , we believe we are well placed to invest and create value in this space by partnering and supporting high quality entrepreneurial teams with innovative ideas, products & business models which can revolutionise the Healthcare industry.
Our promise to entrepreneurs is to be a strategic partner dedicated to helping them grow their business by leveraging our years of experience and industry knowledge and provide them strategic inputs, operational expertise and access to our network of relationships.
Thus, we partner with emerging businesses to push them on the path of regional and global leadership.
MEET OUR TEAM
Asian Healthcare Fund Team
Mr Ajay Kumar Vij
Ajay is a healthcare industry leader and an entrepreneur with global exposure of building, operating and acquiring businesses.
Formerly, Ajay was the CEO of Dabur Pharma Ltd (DPL), a publicly listed and fully integrated global pharmaceutical company. He successfully led the company to become one of the world’s largest specialty oncology groups that operated in 40 countries including USA, Europe, Latin America, and the Asia Pacific region. His 15 year tenure at DPL included the key role in DPL’s landmark alliance in the US with global pharmaceutical giant Abbott and eventually led the sale of the DPL to Fresenius Kabi, a German healthcare conglomerate, in 2008 in a deal valued at approx USD 360 million.
Ajay has wide experience in identifying promising business opportunities, developing growth strategy, structuring global expansion and alliances.
Ajay serves as Non-Executive Director in Dabur Research Foundation, Althea Lifesciences Limited and Talbros Automotive Components Ltd
He holds a MBA and Bachelor degree in Science from Punjab University, Chandigarh, India.
Member
Mr. Sameer Wagle
Sameer joined the Fund from Nomura Securities where he headed the India team for their Private Equity division. He has an overall 26 years of investing and operating experience including over 23 years in the Private Equity / Venture Capital space across leading Indian and International Investment platforms like Nomura, IL&FS, Vertex Management and GVFL.
During his PE career, Sameer has invested in and worked closely with a number of companies & entrepreneurs in the Healthcare, Consumer services and Technology sectors in India and South East Asia.
Prior to his VC experience, Sameer had operational assignments at two Indian engineering companies viz – Crompton Greaves and DGP Windsor.
Sameer is an Electrical Engineer from the University of Pune, an MBA from SP Jain Institute of Management and Research, and a Chartered Financial Analyst (CFA) from the CFA Institute, US.
Sameer is closely associated with and is on the Investment Committee of Aavishkaar, India’s first Social Venture Capital firm. He is also involved with Takshashila an Independent networked think tank on India’s strategic affairs.
Shailendra Tandon
Shailendra Tandon was formerly the CFO of Dabur Pharma Limited. His experience of over four decades is a rich blend of Business Strategy & Operations, M&A, Corporate Finance and HR in multinationals (ICI, Bausch & Lomb and Carrier Aircon) as well as large Indian companies (Indo Rama and Escorts) at the leadership level.
He has served as a member of Boards, member of Management Committees, member of Audit Committees, shared responsibility for delivering bottom lines in various businesses and has mentored business leadership teams.
He has a proven track record of successful corporate transactions, which includes sale of Fertilizer and Fibers business of ICI in 1994, restructuring of Bausch & Lomb India to segregate Ray ban business from the core business in 2000, demerger of the textile business of Indo Rama into a separate company in 2003, sale of Escorts Heart Hospital in 2005 to the Fortis group and sale of Dabur Pharma Limited in 2008 to a European healthcare company, Fresenius Kabi Plc.
Mr Ajay Kumar Vij
Ajay is a healthcare industry leader and an entrepreneur with global exposure of building, operating and acquiring businesses.
Formerly, Ajay was the CEO of Dabur Pharma Ltd (DPL), a publicly listed and fully integrated global pharmaceutical company. He successfully led the company to become one of the world’s largest specialty oncology groups that operated in 40 countries including USA, Europe, Latin America, and the Asia Pacific region. His 15 year tenure at DPL included the key role in DPL’s landmark alliance in the US with global pharmaceutical giant Abbott and eventually led the sale of the DPL to Fresenius Kabi, a German healthcare conglomerate, in 2008 in a deal valued at approx USD 360 million.
Ajay has wide experience in identifying promising business opportunities, developing growth strategy, structuring global expansion and alliances.
Ajay serves as Non-Executive Director in Dabur Research Foundation, Althea Lifesciences Limited and Talbros Automotive Components Ltd
He holds a MBA and Bachelor degree in Science from Punjab University, Chandigarh, India.
Member
Mr. Sameer Wagle
Sameer joined the Fund from Nomura Securities where he headed the India team for their Private Equity division. He has an overall 26 years of investing and operating experience including over 23 years in the Private Equity / Venture Capital space across leading Indian and International Investment platforms like Nomura, IL&FS, Vertex Management and GVFL.
During his PE career, Sameer has invested in and worked closely with a number of companies & entrepreneurs in the Healthcare, Consumer services and Technology sectors in India and South East Asia.
Prior to his VC experience, Sameer had operational assignments at two Indian engineering companies viz – Crompton Greaves and DGP Windsor.
Sameer is an Electrical Engineer from the University of Pune, an MBA from SP Jain Institute of Management and Research, and a Chartered Financial Analyst (CFA) from the CFA Institute, US.
Sameer is closely associated with and is on the Investment Committee of Aavishkaar, India’s first Social Venture Capital firm. He is also involved with Takshashila an Independent networked think tank on India’s strategic affairs.
Shailendra Tandon
Shailendra Tandon was formerly the CFO of Dabur Pharma Limited. His experience of over four decades is a rich blend of Business Strategy & Operations, M&A, Corporate Finance and HR in multinationals (ICI, Bausch & Lomb and Carrier Aircon) as well as large Indian companies (Indo Rama and Escorts) at the leadership level.
He has served as a member of Boards, member of Management Committees, member of Audit Committees, shared responsibility for delivering bottom lines in various businesses and has mentored business leadership teams.
He has a proven track record of successful corporate transactions, which includes sale of Fertilizer and Fibers business of ICI in 1994, restructuring of Bausch & Lomb India to segregate Ray ban business from the core business in 2000, demerger of the textile business of Indo Rama into a separate company in 2003, sale of Escorts Heart Hospital in 2005 to the Fortis group and sale of Dabur Pharma Limited in 2008 to a European healthcare company, Fresenius Kabi Plc.